“…Limitations to stratify public data with correlated demographic data and missing survival data in our cohort preclude definitive actionable clinical conclusions at this time. Although there are ongoing efforts to recruit minorities into existing clinical trials [86,87], these findings highlight the impactful possibilities of utilizing genetic ancestry in multi-ethnic cohorts and the need to demonstrate that variation within and among TNBC subtypes and how genetic ancestry may impact tumor biology, which in could guide treatment decisions. Author Contributions: UM, CY, and MD contributed to the concept, design, and generating; MD, CY, RM, ID, IA, and JW performed the data curation and analyses; IEE, ARF, WG, UM collected breast tissues; IEE, ARF, and WEG performed macro-dissections; MD, CY, RT, WDC, UM, and WG wrote and edited the manuscript.…”